Clinical Trials Logo

Clinical Trial Summary

Blood flow through the popliteal, brachial, and carotid arteries during peripheral heating of the feet


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06192992
Study type Interventional
Source San Diego State University
Contact Jeff Moore, M.S./M.S.
Phone 7146587215
Email Jmoore714@gmail.com
Status Recruiting
Phase N/A
Start date May 31, 2022
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05049278 - Effects of Vasopressor on the Graft Blood Flow in TRAM N/A
Completed NCT01600118 - Effect of Shock Waves on Dental Parameters Phase 2/Phase 3
Active, not recruiting NCT01200433 - The Effects of Dexmedetomidine and Propofol on Cerebral Blood Flow and Brain Oxygenation During Deep Brain Stimulation N/A
Recruiting NCT03807570 - Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow N/A
Recruiting NCT06426823 - The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes N/A
Withdrawn NCT02871310 - Vasoactive Effects of IQP-AS-118 in Healthy Individuals N/A
Completed NCT01689051 - Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus N/A
Completed NCT06186297 - Boosting Performance: The Power of Cranberry Supplementation N/A
Completed NCT05399771 - Radiofrequency Hyperthermia Safety Study N/A
Withdrawn NCT05042349 - Pregnant Elite Athletes and Pregnant Women Exercising With Moderate Intensity
Completed NCT03127917 - Effect of L-Citrulline on Vascular Function N/A
Recruiting NCT04389125 - Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow N/A
Completed NCT05391581 - The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism N/A
Not yet recruiting NCT04232111 - Effect of AVACEN 100 on Brachial Artery Blood Flow and Heart Rate Variability N/A
Recruiting NCT06238609 - Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome Phase 1